Insider track record
OtherAcross 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by GIRGENTI STEVEN. Officer active across 2 companies, notably bioAffinity Technologies, Inc.. Aggregated, 11 disclosures have been published. History available since 6 September 2022. The latest transaction was filed on 10 January 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
14,814 shares0Common StockSEC:0001493152-25-002148:0
33,784 shares0Common StockSEC:0001493152-24-026092:0
8,296 shares0Common StockSEC:0001493152-24-023994:0
64,848 shares@ US$1.1633.0% of flowCommon StockSEC:0001493152-24-015789:0
39,474 shares@ US$1.5226.5% of flowCommon StockSEC:0001493152-24-012014:0
11,943 shares0Common StockSEC:0001493152-24-004760:0
11,867 shares@ US$1.588.4% of flowCommon StockSEC:0001493152-24-003691:0
8,227 shares@ US$2.288.4% of flowCommon StockSEC:0001493152-23-027815:0
8,227 shares@ US$2.288.4% of flowCommon StockSEC:0001493152-23-023821:0
7,657 shares@ US$4.2015.4% of flowCommon StockSEC:0001493152-22-030872:0
5,682 sharesVycor Medical Inc. Common Stock pure value $0.0001SEC:0001354488-16-005860:0